MKI67 and neoplasm: In the overall cohort (n = 167), median (IQR) values were biopsy tumor size 20.0 mm (14.0–26.0), pathologic invasive tumor size 25.0 mm (19.5–40.0), Ki-67 15.0% (10.0–30.0), A-TTS 35.0 days (25.0–51.5), B-TTS 16.0 days (9.0–25.0), A–B 15.0 days (10.0–24.0), surgery-to-adjuvant interval 43.0 days (33.5–55.5), survival time 58.0 months (38.0–110.0), and follow-up time 52.0 months (33.5–72.0).